Table 2.
Current clinical uses of ECMO for COVID-19
| Application | Study design | Cases on ECMO (total cases) | Outcomes of ECMO | Reference |
|---|---|---|---|---|
| Critically ill patients with SARS-CoV-2 pneumonia | Single center, retrospective, study | 6 (52) | Five patients died while one patient was still on ECMO at the endpoint | (Yang et al., 2020) |
| Patients with ARDS caused by SARS-CoV-2 | Single center, retrospective study | 10 (221) | Two patients were discharged, three patients died, and five patients were still on ECMO at the endpoint | (Guqin et al., 2020) |
| Critically ill patients with SARS-CoV-2 pneumonia | Single center, retrospective study | 4 (138) | NA | (Guan et al., 2020) |
| Critically ill patients with SARS-CoV-2 pneumonia | Multicenter retrospective study | 5 (1099) | NA | (Huang et al., 2020) |
| Critically ill patients with SARS-CoV-2 pneumonia | Single center prospective study | 2 (41) | NA | (Brodie et al., 2019) |
ARDS = acute respiratory distress syndrome; COVID-19= coronavirus disease 2019; ECMO = extracorporeal membrane oxygenation; NA = not available; SARS-CoV-2= severe acute respiratory syndrome coronavirus 2.